- JP-listed companies
- AnGes, Inc.
- Dividends
AnGes, Inc. (4563) Dividends
Market cap
¥22.9B
P/E ratio
-2.2x
AnGes develops gene medicines and nucleic acid treatments, while providing genetic screening tests for rare disorders through its clinical research laboratory.
Latest Dividend per Share Forecast
0.00JPY
If you buy 100 shares of AnGes, Inc., the expected annual dividend is 0 JPY.
- Dividend Yield
- -
- Payout Ratio
- -
Dividend Policy
<p>Currently, as a drug discovery bioventure in the pre-revenue investment stage, we are not paying dividends. However, we recognize shareholder returns as an important management priority. Once our pipeline drugs reach market and generate profits, we plan to consider dividends based on our financial performance and condition at that time. Our articles of incorporation provide for dividends twice annually (fiscal year-end and interim).</p>
Dividend per Share
Payout Ratio
Dividend Yield
Dividend History (Forecasts, Revisions, Actuals)
| Fiscal Year | Type | Interim | Year-End | Total | Payout Ratio |
| FY2026 | Forecast(2026/02/10) | 0 | 0 | 0 | - |
|---|---|---|---|---|---|
| FY2025 | Actual(2026/02/10) | 0 | 0 | 0 | - |
| Forecast(2025/02/14) | 0 | 0 | 0 | - | |
| FY2024 | Actual(2025/02/14) | 0 | 0 | 0 | - |
| Forecast(2024/02/09) | 0 | 0 | 0 | - | |
| FY2023 | Actual(2024/02/09) | 0 | 0 | 0 | - |
| Forecast(2023/02/10) | 0 | 0 | 0 | - | |
| FY2022 | Actual(2023/02/10) | 0 | 0 | 0 | - |
| Forecast(2022/02/10) | 0 | 0 | 0 | - | |
| FY2021 | Actual(2022/02/10) | 0 | 0 | 0 | - |
| Forecast(2021/02/15) | 0 | 0 | 0 | - | |
| FY2020 | Actual(2021/02/15) | 0 | 0 | 0 | - |
| Forecast(2020/10/26) | 0 | 0 | 0 | - | |
| FY2019 | Actual(2020/10/26) | 0 | 0 | 0 | - |